Furthermore, many chemotherapeutic agents, such as Gem, have been shown to activate NF-κB in PaCa cells [18]. This evidence concerns the gene NFKB1 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.